BHST BioHarvest Sciences Inc: Accounting Value per Share

Graphic logo of BioHarvest Sciences (BHST)

The price action of BioHarvest Sciences (BHST) reflects the development of a business that has created an innovative method for cultivating plant cells in reactors for medical use, which eliminates direct competition. The current indicator is 0.87. BioHarvest Sciences (BHST) attracts health-conscious consumers through direct sales, despite the differences in US and European regulations. A high barrier to entry is ensured by proprietary soil-free biomass synthesis schemes.

BioHarvest Sciences, Inc. (BHST): Share Book Value from 11/13/2024 to 10/27/2026

bioharvest.com - analytical breakdowns and key metrics (BHST)

- price and consensus price forecast:
Price Chart BioHarvest|BHST - Analyst Median Target
- market capitalization data:
Market Valuation BioHarvest Sciences Inc.|BHST - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share BioHarvest Sciences|BHST - Net Asset Value|Market Capitalization to Book Value Ratio bioharvest.com|BHST - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital BioHarvest Sciences|BHST - Long-Term Debt to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc.|BHST - Aggregate Debt Obligations|Debt to Book Capitalization Ratio BioHarvest Sciences Inc.
Fundamental company valuation:BioHarvest - BHST
Manufactured products of BioHarvest Sciences Inc.

Book value per share measures a company's net assets, reflecting the accumulation of property and the intrinsic value of the business net of liabilities. This indicator serves as a portfolio stress-testing tool, and the current book value per share of BioHarvest Sciences (BHST) confirms capitalization potential driven by biosynthesis scalability, where increased reactor utilization reduces costs and grows equity.

Competitors of BioHarvest Sciences (BHST)

Net Assets per Single Share HLN (Haleon Group)|Kenvue Health (KVUE) - Net Assets per Share|VRNA - Accounting Value per Share|MENS (jyongbio.com) - Book Price of a Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|Book Value per Share Quantum BioPharma QNTM|Net Assets per Single Share FibroGen Inc FGEN|Book Value per Share TELO (Telomir Pharma)|RANI: Net Assets per Share|Net Assets per Single Share SNYR|Rallybio (RLYB) - Net Asset Value per Share|LEXX - Book Value per Share|Accounting Value of a Share Pulmatrix Inc|Book Value per Share PTHL|Book Value per Share APM (aptorumgroup.com)|Net Assets per Single Share Lyra Therapeutics, Inc.|IBO - Accounting Value of a Share|TNFA - Accounting Value per Share|YCBD - Net Assets per Single Share|Book Value per Share PRFX|CYTO (Altamira Therapeutics Ltd.) - Net Asset Value per Share|LIPO: Net Assets per Single Share|Net Assets per Share optinose.com (OPTN)|Accounting Value per Share Pieris Pharmaceuticals, Inc.|Book Price of a Share Procaps Group PROC|Accounting Value per Share Petros|Qilian International Corp - Accounting Value of a Share|Net Assets per Single Share SLRN (Acelyrin, Inc.)|TFFP - Net Assets per Share